Skip to main content

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Alejandro Saiz Domenech

Alejandro Saiz Domenech

Research technician
Nephrology and kidney transplantation
Read more
Teodora Pribic

Teodora Pribic

Postdoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Eniruqe Alberto Vargas Meouchi

Eniruqe Alberto Vargas Meouchi

Research technician
Reconstructive Surgery of the Locomotor System
Read more
Silvia Alarcón Portabella

Silvia Alarcón Portabella

Research assistant
Ophtalmology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.